AmbioPharm, Inc.

AmbioPharm is a leading, innovation-driven peptide CDMO with headquarters in the USA and manufacturing campuses both in the USA and Asia. With a comprehensive range of services and scales, AmbioPharm produces custom products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

View Site